Bringing the fundamentals into focus…
Back to Atara Biotherapeutics, Inc.
How Atara Biotherapeutics, Inc. stacks up
ATRA · against 1,335 other Healthcare companies
Profitability
29/ 100
Below the middle of the pack.
Ranked #943 of 1,336 · scores higher than 29% of peers
Bars: peers in each 10-point band of the profitability score133 peers with a profitability score of 20–29, including ATRA · Click a bar to see the companies
Why profitability scores 29?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets, which is weaker than most Healthcare peers.
- a lower return on assets: weaker than 83% of peers. Return on assets: -24.1% vs peer median 1.7%
- Return on invested capital is not reported, so it is left out of the score.
- a wider operating margin: stronger than 92% of peers. Operating margin: 29.7% vs peer median 7.1%
Metric by metric
Position: dot = ATRA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ATRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | Not reported | 4.7% | — | — | 33% |
| Operating marginHigher is better · 1,251 reported | 29.7% | 7.1% | 92% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -24.1% | 1.7% | 17% | 33% | |
| Return on equityHigher is better · 1,252 reported | Not reported | 3.2% | — | — | Context only |
| Gross marginHigher is better · 1,394 reported | 75.3% | 45.9% | 83% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around ATRA| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 943 | 145.4B JPY (≈$989M) | 29 | 36 | |
| 943 | 31.0B CNY (≈$4.3B) | 29 | 26 | |
| 943 | 201M USD | 29 | 24 | |
| 943 | 782M USD | 29 | 35 | |
| 943 | 82M USD | 29 | 27 | |
| 943 | 2.9B USD | 29 | 44 | |
| 943 | 487M USD | 29 | 29 | |
| 943 | 1.8B USD | 29 | 31 | |
| 943 | 464M USD | 29 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score